When Leadership Gets Real

<p>What does it really take to lead a biotech company when the science is complex, the stakes are high and the answers aren’t always obvious?</p><p>In this episode of <strong>She Leads Biotech</strong>, I’m joined by <strong>Iris Grossman, PhD, CEO of Zelig Therapeutics</strong>, for a candid conversation about the realities of biotech leadership and her journey from scientist to CEO.</p><p>In <strong>When Leadership Gets Real: Ego, Accountability &amp; the Decisions That Shape Biotech Companies</strong>, we talk about what happens when leadership moves beyond the title and you become the person ultimately accountable for the decisions.</p><p>We explore why great leaders surround themselves with people who will challenge them, how founders and leadership teams need to evolve as companies grow, why strategy starts with knowing your values, and what Iris has learned about hiring beyond technical capability.</p><p>Iris also talks openly about making decisions without perfect information, handling difficult performance conversations, keeping ego out of leadership — and why patient impact remains her North Star.</p><p><strong>Chapters</strong></p><p>00:00 Introduction<br>03:17 A Patient-Centric North Star<br>05:46 The Scientist Inside the CEO<br>07:04 Turning Science into Patient Impact<br>10:14 The Reality of CEO Accountability<br>13:30 When Founders and Companies Need to Evolve<br>14:39 Why Independent Boards Matter<br>15:43 Strategy Starts with Values<br>17:17 Why Zelig Became a Call to Action<br>20:01 Making Decisions Through Uncertainty<br>23:28 Why Personality Matters in Hiring<br>26:24 The Difficult People Decisions Leaders Must Make<br>30:09 Why Biotech Is Ultimately About People</p><p>🎧 <strong>Follow She Leads Biotech for more conversations with the people building, leading and shaping biotech.</strong></p><p>#SheLeadsBiotech #BiotechLeadership #Biotech #LifeSciences #WomenInBiotech #Leadership</p><p></p>